1-2 of 2
Dietger Niederweiser, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical Relevance of Morphologic and Molecular Complete Remission in AML Patients Undergoing Reduced Intensity or Non-Myeloablative Conditioning

Madlen Jentzsch, MD, Dominic Brauer, Juliane Grimm, MD, Marius Bill, MD PhD, Donata Backhaus, MD, Julia Schulz, Dietger Niederweiser, MD, Uwe Platzbecker, Sebastian Schwind, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 29.
https://doi.org/10.1182/blood-2020-134102
Published: 2020
Journal Articles

Primary Analysis of Anti-CD19 Tafasitamab (MOR208) Treatment in Combination with Idelalisib or Venetoclax in R/R CLL Patients Who Failed Prior BTK Inhibitor Therapy (COSMOS Trial)

Philipp Bernhard Staber, MD PhD, Wojciech Jurczak, Wolfram Brugger, Asher A. Chanan-Khan, MD, Richard Greil, MD, Andrzej Hellmann, MD PhD, Maren Dirnberger-Hertweck, PhD, Peter Kelemen, Jan Moritz Middeke, MD, Marco Montillo, MD, Marina Motta, MD, Talha Munir, MD, Peter Neumeister, MD, Dietger Niederweiser, MD, Sameer A. Parikh, MD, Johannes Schetelig, MDMSc, Stephan Stilgenbauer, Vladan Vucinic, MD, Johannes Weirather, PhD, Jennifer Woyach, MD, Clemens-Martin Wendtner
Journal: Blood
Blood (2019) 134 (Supplement_1): 1754.
https://doi.org/10.1182/blood-2019-128388
Published: 2019